Caplight Directory>Companies>MUSTBIO-preview>Mustbio


MUSTBIO

MUSTBIO

Private
SuwonHealthcare & Life Scienceshttp://mustbio.com/en/

Last Round

Series C

Mar 14, 2026

Est. Valuation

$63.1M

Total Funding Raised

$66.1M

Company Overview

MUSTBIO is a biotechnology company that develops multi-specific antibody-based cancer immunotherapies using its proprietary BICSTA™ and STARKINE™ platforms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

immuno-oncologymulti-specific antibodyimmuno-cytokinebiotech licensingdrug discovery platformfusion proteinengineered cytokinebiologics engineeringIO therapytumor-selective therapypreclinical drug developmentcytokine therapybispecific antibodytrispecific antibodynext-gen immunotherapyIL-2 variantdrug discovery enginecold tumor therapysolid tumor therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MUSTBIO Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MUSTBIO Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CMar 14, 2026
Series CMar 13, 2026
Series BDec 8, 2022
Series AMay 24, 2021
View all Funding Rounds

Key People

Founding team and executive leadership

김맹섭

Chief Executive Officer

Executive Team

MUSTBIO Investors

Notable investors and investment history

InvestorRounds
BNH INVESTMENTSeries C
Korea Investment PartnersSeries C, Series B, Series A
Premier PartnersSeries C, Series B, Series A
Wonik Investment PartnersSeries C, Series B
San-eun InvestmentSeries C
Korea Development BankSeries C, Series B
Partners InvestmentSeries C, Series B, Series A
View all Investors

MUSTBIO Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MUSTBIO Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MUSTBIO's valuation, stock price, and market status.

Firmographic Details

HeadquartersSuwon
Employee Range5
Year Founded2021
Last FundingMar 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.